Postoperative Radiotherapy Plus Iressa or Radiotherapy plus Cisplatin and Iressa for Advanced Head & Neck Cancer - IRESSA&H&N

Study identifier:1839IL/0525

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa or Hyperfractionated Radiotherapy plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial

Medical condition

head and neck cancer

Phase

Phase 1

Healthy volunteers

No

Study drug

Gefitinib

Sex

All

Actual Enrollment

30

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Feb 2004
Primary Completion Date: 01 Oct 2009
Study Completion Date: 01 Oct 2009

Study design

Allocation: Non-randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria